Deals Today

	Click to View in Browser 12/19/2013 Bayer wins cancer firm Algeta with raised $2.9 billion bid FRANKFURT/OSLO (Reuters) - Bayer has won backing from the board of Algeta , its partner for a new prostate cancer treatment, for an increased $2.9 billion offer to buy the Norwegian company. AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion LONDON (Reuters) - AstraZeneca has agreed to buy Bristol-Myers Squibb's stake in the companies' diabetes joint venture for up to $4.1 billion in a deal that will help return the group to growth, sending its shares to a new high. Carlyle ventures into Europe's ailing refining sector VIENNA (Reuters) - Private equity giant Carlyle Group made a surprise foray into Europe's struggling refining sector by teaming up with Swiss trading house Vitol to co-own refining, storage and distribution assets in Switzerland and Germany. True Corp $1.8 billion fund IPO sidesteps Thai market gloom BANGKOK (Reuters) - True Corp Pcl , Thailand's largest full-service telecoms company, has pulled off the $1.8 billion sale of a fund housing its infrastructure assets, skirting a market slide to land the second-biggest Thai initial public offering of 2013. Carlyle, KKR advance in Transpacific NZ waste unit sale-sources HONG KONG/SYDNEY (Reuters) - Carlyle Group and KKR have advanced in the sale of Transpacific Industries Group Ltd's waste management unit, in a deal that could fetch around NZ$880 million ($725.5 million), people familiar with the matter told Reuters. Saab wins Brazil jet deal after NSA spying sours Boeing bid BRASILIA/SAO PAULO (Reuters) - Brazil awarded a $4.5 billion contract to Saab AB on Wednesday to replace its aging fleet of fighter jets, a surprise coup for the Swedish company after news of U.S. spying on Brazilians helped derail Boeing's chances for the deal. Bristol close to selling diabetes stake to Astra for $3 billion: WSJ (Reuters) - Bristol-Myers Squibb Co is close to selling its stake in a diabetes partnership with AstraZeneca Plc to the British drugmaker in a deal valued at more than $3 billion, the Wall Street Journal reported on Wednesday. Carlyle taps Credit Suisse to explore $3 billion sale of PQ: sources NEW YORK (Reuters) - Carlyle Group LP has hired Credit Suisse Group AG to explore a sale of specialty chemical company PQ Corp, which it is hoping to sell for as much as $3 billion, according to three people familiar with the matter. Exclusive: Dish eyes 2014 bid for T-Mobile - sources (Reuters) - Dish is considering making a bid for T-Mobile next year, according to people close to the matter, in what would be the satellite TV provider's second attempt in as many years at acquiring a major wireless operator and potentially setting the stage for a new bidding war with Softbank . AirAsiaX seeks connectivity with $6 billion Airbus jet deal PARIS (Reuters) - Malaysian budget carrier AirAsiaX placed a $6 billion order for 25 Airbus A330-300 aircraft on Wednesday in a bid to challenge network carriers by piggy-backing off the success of Asia's largest low-cost airline, AirAsia. Related Video China bitcoin exchange plots future after crackdown Reuters Today: No taper tantrums as equities soar Related News Fed cuts bond buying in first step away from historic stimulus Senate passes budget deal, focus shifts to spending A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend